pubs.rsc.org/ee/article-abstract/9/6/1863/523086PDF

Advances in high permeability polymer-based membrane materials for CO2 separations

www.jci.org/articles/view/31911PDF

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2, 3-dioxygenase

… The IDO + cells in TDLNs of all 3 tumor lines were similar; for most cell-sorting experiments B78H1–GM-CSF tumors were used, as in our previous publications (1, 9), because these …

www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30180...

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

… The trial took place between April 25, 2013, and Sept 18, 2018; median follow-up was 4·2 years (IQR 3·9–4·4). Of the 17 160 participants who were randomly assigned, 8162 (47·6%) …

pubs.acs.org/doi/abs/10.1021/ar800057k

Poly (2, 7-carbazole) s: structure− property relationships

ashpublications.org/blood/article-abstract/78/5/1205/46639

Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation [published erratum appears in Blood 1992 Jun …

… From November 1989 to September 1990, 30 consecutive patients were enrolled in this … Levels in excess of 30 pgimL ( 2 2 standard deviations above mean normal control values n = 20…

www.thelancet.com/journals/lanonc/article/PIIS147020450970364X/a...PDF

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an …

… Median progression-free survival was 9·2 months (95% CI 8·0–13·9) in the gefitinib group and 6·3 months (5·8–7·8) in the cisplatin plus docetaxel group (p<0·0001; figure 2A). Gefitinib …

www.thelancet.com/journals/lanonc/article/PIIS1470204507702462/a...

Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data

… ·2–79·9]), and prostate cancer (77·5% [76·5–78·6]); and low for stomach cancer (24·9% [23·7–26·2]), chronic myeloid leukaemia (32·2… [13·4–16·4]), and lung cancer (10·9% [10·5–11·4]). …

www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00203...PDF

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised …

… The BMI categories used were less than 32 kg/m 2 and 32 kg/m 2 or greater in REWIND, and less than median 31·9 kg/m 2 and median 31·9 kg/m 2 or greater in AMPLITUDE-O. ¶The …

pubs.acs.org/doi/full/10.1021/cr030677f

Construction of pyridine rings by metal-mediated [2+ 2+ 2] cycloaddition

… of types 4 and 6, 8 evidence for 2 and 5 is lacking. To elucidate the path from 4 to 6, a theoretical study has therefore been carried out: 9 according to density functional theory (DFT) and …

onlinelibrary.wiley.com/doi/abs/10.1002/pip.822PDF

19·9%‐efficient ZnO/CdS/CuInGaSe2 solar cell with 81·2% fill factor

We report a new record total‐area efficiency of 19·9% for CuInGaSe 2 ‐based thin‐film solar cells. Improved performance is due to higher fill factor. The device was made by three‐stage …